Cencora has completed a restructuring of its operating model and reportable segments to align with growth priorities. Beginning in the first quarter of fiscal 2027, the company will operate under three segments: Pharmaceutical Distribution and Services, Specialty Pharmaceutical and Provider Services, and Other. The 'Other' category includes businesses for which Cencora is exploring strategic alternatives, specifically MWI Animal Health, Profarma, and components of PharmaLex. The filing provides supplemental unaudited revised segment revenue and operating income data for fiscal 2026 and 2025 under the new structure to assist investor analysis. Cencora operates in the healthcare distribution industry.
